-
May 9: The Week in Cancer News
A single dose of HPV vaccine is highly effective, and not all cancers are increasing in people under 50.
by Kevin McLaughlin
-
May 2: The Week in Cancer News
Immunotherapy may treat some early-stage cancer patients without the need for surgery, and exercise found to counter many side effects of cancer treatment.
by Eric Fitzsimmons
-
April 25: The Week in Cancer News
People with metabolic syndrome may have elevated risk for breast cancer mortality, and immunotherapy keeps lung cancer at bay even after discontinuing treatment.
by Thomas Celona
-
April 18: The Week in Cancer News
Gaps in goals-of-care discussions may harm young adults with cancer, and 1 in 6 participants in phase II trials get treatments that are eventually approved by the FDA.
by Marci A. Landsmann
-
April 11: The Week in Cancer News
NIH layoffs delay research benefiting cancer patients, and celebrity cancer news is often missing important information.
by Kevin McLaughlin
-
April 4: The Week in Cancer News
Some early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.
by Eric Fitzsimmons
-
March 28: The Week in Cancer News
New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.
by Thomas Celona
-
March 21: The Week in Cancer News
Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
by Marci A. Landsmann
-
March 14: The Week in Cancer News
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
by Kevin McLaughlin
-
March 7: The Week in Cancer News
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
by Thomas Celona
Cancer Talk
Amanda Peet Discusses Her Lobular Breast Cancer Diagnosis
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
